By studying these models, we can understand how altered USP7 and TRIP12 activity influences chromatin remodeling and DNA methylation, crucial for neurodevelopmental disorders and providing insights into disease mechanisms and potential therapeutic targets. This evidence concerns the gene USP7 and neurodevelopmental disorder.